Medical Companies

August 15, 2009

Theregen Corporation

Filed under: Biotechnology — Tags: — medical products @ 1:48 pm

Industry: Pharmaceuticals, Biotechnology
Theregen, Inc. (formerly Iken Tissue Therapeutics) is a regenerative medicine company that develops cell-based therapies for patients with cardiovascular and vascular disease. Theregen has worldwide exclusive rights to research, manufacture, develop and commercialize its lead product, Anginera,, for cardiovascular and vascular applications. The company is conducting a Phase I human clinical safety trial for Anginera, a cell-based epicardial therapy. Anginera has been shown in animal models to have the potential to induce remodeling and angiogenesis in the ischemic heart, leading to functional changes that may benefit patients with heart ( www.theregeninc.com )

Theregen Corporation
225 Bush St. 16Th Flr.
San Francisco, California 94104
USA

Tel: (415) 439-8320
Fax: (415) 439-8322

  • Boehringer Ingelheim Corporation
  • SciClone Pharmaceuticals , Inc.
  • Air Trek Inc.
  • BioMS Medical Corp.
  • Nanjing Clasien Pharmaceutical & Chemical Co., Ltd.
  • Cell
  • Nereus Pharmaceuticals , Inc.
  • Actelion Ltd
  • Palatin Technologies , Inc.
  • Neuro Bioscience Inc
  • Fibromyalgia Centers of America
  • EnCor Biotechnology Inc
  • GenUs BioSystems Inc
  • Targeted Diagnostics & Therapeutics , Inc
  • Hematech , LLC
  • Trophogen , Inc
  • Agencourt Bioscience Corporation
  • Theravance , Inc.
  • International Stem Cell Corporation
  • Gel Med Sciences , Inc.
  • Medical Companies - Medical Companies Sitemap